• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-1 和 miR-133a 通过靶向 TAGLN2 抑制膀胱癌的肿瘤抑制功能。

The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.

机构信息

Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan.

出版信息

Br J Cancer. 2011 Mar 1;104(5):808-18. doi: 10.1038/bjc.2011.23. Epub 2011 Feb 8.

DOI:10.1038/bjc.2011.23
PMID:21304530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3048214/
Abstract

BACKGROUND

On the base of the microRNA (miRNA) expression signature of bladder cancer (BC), we found that miR-1 and miR-133a were significantly downregulated in BC. In this study, we focussed on the functional significance of miR-1 and miR-133a in BC cell lines and identified a molecular network of these miRNAs.

METHODS AND RESULTS

We investigated the miRNA expression signature of BC clinical specimens and identified several downregulated miRNAs (miR-133a, miR-204, miR-1, miR-139-5p, and miR-370). MiR-1 and miR-133a showed potential role of tumour suppressors by functional analyses of BC cells such as cell proliferation, apoptosis, migration, and invasion assays. Molecular target searches of these miRNAs showed that transgelin 2 (TAGLN2) was directly regulated by both miR-1 and miR-133a. Silencing of TAGLN2 study demonstrated significant inhibitions of cell proliferation and increase of apoptosis in BC cell lines. The immunohistochemistry showed a positive correlation between TAGLN2 expression and tumour grade in clinical BC specimens.

CONCLUSIONS

The downregulation of miR-1 and miR-133a was a frequent event in BC, and these miRNAs were recognised as tumour suppressive. TAGLN2 may be a target of both miRNAs and had a potential oncogenic function. Therefore, novel molecular networks provided by miRNAs may provide new insights into the underlying molecular mechanisms of BC.

摘要

背景

在膀胱癌(BC)的 microRNA(miRNA)表达特征的基础上,我们发现 miR-1 和 miR-133a 在 BC 中显著下调。在这项研究中,我们专注于 miR-1 和 miR-133a 在 BC 细胞系中的功能意义,并确定了这些 miRNA 的分子网络。

方法和结果

我们研究了 BC 临床标本的 miRNA 表达特征,确定了几个下调的 miRNA(miR-133a、miR-204、miR-1、miR-139-5p 和 miR-370)。miR-1 和 miR-133a 通过 BC 细胞的功能分析(如细胞增殖、凋亡、迁移和侵袭测定)显示出肿瘤抑制因子的潜在作用。这些 miRNA 的分子靶标搜索表明,转凝胶蛋白 2(TAGLN2)被 miR-1 和 miR-133a 直接调控。TAGLN2 沉默研究表明,BC 细胞系中的细胞增殖受到显著抑制,凋亡增加。免疫组织化学显示,临床 BC 标本中 TAGLN2 表达与肿瘤分级呈正相关。

结论

miR-1 和 miR-133a 的下调在 BC 中是一个常见事件,这些 miRNA 被认为是肿瘤抑制因子。TAGLN2 可能是这两个 miRNA 的靶点,具有潜在的致癌功能。因此,miRNA 提供的新分子网络可能为 BC 的潜在分子机制提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966d/3048214/bfc96e59563a/bjc201123f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966d/3048214/d065961b8153/bjc201123f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966d/3048214/8ba0e2a3a42b/bjc201123f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966d/3048214/fc05ba333fd7/bjc201123f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966d/3048214/906f00df1332/bjc201123f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966d/3048214/3af895b8c4c7/bjc201123f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966d/3048214/80c2dd06aff6/bjc201123f6a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966d/3048214/bfc96e59563a/bjc201123f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966d/3048214/d065961b8153/bjc201123f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966d/3048214/8ba0e2a3a42b/bjc201123f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966d/3048214/fc05ba333fd7/bjc201123f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966d/3048214/906f00df1332/bjc201123f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966d/3048214/3af895b8c4c7/bjc201123f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966d/3048214/80c2dd06aff6/bjc201123f6a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966d/3048214/bfc96e59563a/bjc201123f7.jpg

相似文献

1
The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.miR-1 和 miR-133a 通过靶向 TAGLN2 抑制膀胱癌的肿瘤抑制功能。
Br J Cancer. 2011 Mar 1;104(5):808-18. doi: 10.1038/bjc.2011.23. Epub 2011 Feb 8.
2
The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.通过深度测序分析膀胱癌的微小RNA表达特征:miR-195/497簇的功能意义
PLoS One. 2014 Feb 10;9(2):e84311. doi: 10.1371/journal.pone.0084311. eCollection 2014.
3
The functional significance of miR-1 and miR-133a in renal cell carcinoma.miR-1 和 miR-133a 在肾细胞癌中的功能意义。
Eur J Cancer. 2012 Apr;48(6):827-36. doi: 10.1016/j.ejca.2011.06.030.
4
Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma.鉴定受抑癌 miR-1/miR-133a 调控的上颌窦鳞癌细胞中的新型分子靶标。
Int J Oncol. 2011 Nov;39(5):1099-107. doi: 10.3892/ijo.2011.1096. Epub 2011 Jun 23.
5
miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer.miR-145 和 miR-133a 作为肿瘤抑制因子发挥作用,直接调控膀胱癌中 FSCN1 的表达。
Br J Cancer. 2010 Mar 2;102(5):883-91. doi: 10.1038/sj.bjc.6605570. Epub 2010 Feb 16.
6
MicroRNA-133b suppresses bladder cancer malignancy by targeting TAGLN2-mediated cell cycle.微小 RNA-133b 通过靶向 TAGLN2 介导的细胞周期抑制膀胱癌恶性表型。
J Cell Physiol. 2019 Apr;234(4):4910-4923. doi: 10.1002/jcp.27288. Epub 2018 Oct 14.
7
miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma.作为一种靶向TAGLN2的肿瘤抑制性微小RNA,miR-1在头颈部鳞状细胞癌中的作用
Oncotarget. 2011 Jan-Feb;2(1-2):29-42. doi: 10.18632/oncotarget.213.
8
Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer.膀胱癌中肿瘤抑制因子 microRNA-1 和 microRNA-133a 调控的新型分子靶标。
Int J Oncol. 2012 Jun;40(6):1821-30. doi: 10.3892/ijo.2012.1391. Epub 2012 Feb 29.
9
Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.LASP1 在细胞活力中的功能作用及其在膀胱癌中受 microRNAs 的调控。
Urol Oncol. 2012 Jul-Aug;30(4):434-43. doi: 10.1016/j.urolonc.2010.05.008. Epub 2010 Sep 16.
10
MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines.miR-133a 通过直接调控 GSTP1 诱导膀胱癌细胞系凋亡。
Urol Oncol. 2013 Jan;31(1):115-23. doi: 10.1016/j.urolonc.2010.09.017. Epub 2011 Mar 10.

引用本文的文献

1
Purine Nucleoside Phosphorylase (PNP) as a Biomarker and Therapeutic Target in Muscle-Invasive Bladder Cancer.嘌呤核苷磷酸化酶(PNP)作为肌层浸润性膀胱癌的生物标志物和治疗靶点
Clin Med Insights Oncol. 2025 Aug 10;19:11795549251359145. doi: 10.1177/11795549251359145. eCollection 2025.
2
TAGLN2-mediated Actin Cytoskeleton Stabilization Promotes Proliferation and Metastasis of Ovarian Carcinoma.TAGLN2介导的肌动蛋白细胞骨架稳定促进卵巢癌的增殖和转移。
Appl Immunohistochem Mol Morphol. 2025 Apr 18. doi: 10.1097/PAI.0000000000001261.
3
Epigenetic modifications in bladder cancer: crosstalk between DNA methylation and miRNAs.

本文引用的文献

1
MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines.miR-133a 通过直接调控 GSTP1 诱导膀胱癌细胞系凋亡。
Urol Oncol. 2013 Jan;31(1):115-23. doi: 10.1016/j.urolonc.2010.09.017. Epub 2011 Mar 10.
2
miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.miR-145、miR-133a 和 miR-133b:抑癌 miRNAs 在食管鳞癌细胞中靶向 FSCN1。
Int J Cancer. 2010 Dec 15;127(12):2804-14. doi: 10.1002/ijc.25284.
3
Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
膀胱癌中的表观遗传修饰:DNA甲基化与微小RNA之间的相互作用
Front Immunol. 2025 Feb 5;16:1518144. doi: 10.3389/fimmu.2025.1518144. eCollection 2025.
4
LncRNA BCYRN1 as a Potential Therapeutic Target and Diagnostic Marker in Serum Exosomes in Bladder Cancer.长链非编码 RNA BCYRN1 作为膀胱癌血清外泌体中潜在的治疗靶点和诊断标志物。
Int J Mol Sci. 2024 May 29;25(11):5955. doi: 10.3390/ijms25115955.
5
miR-133a and miR-135a Regulate All-Trans Retinoic Acid-Mediated Differentiation in Pediatric Acute Myeloid Leukemia by Inhibiting CDX2 Translation and Serve as Prognostic Biomarkers.miR-133a 和 miR-135a 通过抑制 CDX2 翻译调控全反式维甲酸诱导的小儿急性髓系白血病分化并作为预后生物标志物。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241248576. doi: 10.1177/15330338241248576.
6
Transgelin-2, a novel cancer stem cell-related biomarker, is a diagnostic and therapeutic target for biliary tract cancer.Transgelin-2,一种新型的癌症干细胞相关生物标志物,是胆管癌的诊断和治疗靶点。
BMC Cancer. 2024 Mar 20;24(1):357. doi: 10.1186/s12885-024-12082-3.
7
Circular STAG2 RNA Modulates Bladder Cancer Progression via miR-145-5p/TAGLN2 and Is Considered as a Biomarker for Recurrence.环状STAG2 RNA通过miR-145-5p/TAGLN2调节膀胱癌进展,并被视为复发的生物标志物。
Cancers (Basel). 2024 Feb 28;16(5):978. doi: 10.3390/cancers16050978.
8
Down-regulation of miR-133a-3p protects lung tissue against sepsis-induced acute respiratory distress syndrome by up-regulating SIRT1.miR-133a-3p的下调通过上调SIRT1来保护肺组织免受脓毒症诱导的急性呼吸窘迫综合征的影响。
Arch Med Sci. 2020 Apr 14;20(1):289-301. doi: 10.5114/aoms.2020.94410. eCollection 2024.
9
Elucidating the Associated Biological Function and Clinical Significance of Expression in Urothelial Carcinoma.阐明 在尿路上皮癌中的表达相关的生物学功能和临床意义。
Int J Mol Sci. 2023 Sep 14;24(18):14081. doi: 10.3390/ijms241814081.
10
Characterization and treatment of gemcitabine- and cisplatin-resistant bladder cancer cells with a pan-RAS inhibitor.用泛 RAS 抑制剂对吉西他滨和顺铂耐药的膀胱癌细胞进行鉴定和治疗。
FEBS Open Bio. 2023 Jun;13(6):1056-1066. doi: 10.1002/2211-5463.13616. Epub 2023 Apr 29.
LASP1 在细胞活力中的功能作用及其在膀胱癌中受 microRNAs 的调控。
Urol Oncol. 2012 Jul-Aug;30(4):434-43. doi: 10.1016/j.urolonc.2010.05.008. Epub 2010 Sep 16.
4
Cancer statistics, 2010.癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
5
Genetic variation in microRNA networks: the implications for cancer research.miRNA 网络中的遗传变异:对癌症研究的影响。
Nat Rev Cancer. 2010 Jun;10(6):389-402. doi: 10.1038/nrc2867.
6
MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer.miRNA 簇 221-222 与乳腺癌中雌激素受体 α 的相互作用。
J Natl Cancer Inst. 2010 May 19;102(10):706-21. doi: 10.1093/jnci/djq102. Epub 2010 Apr 13.
7
Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis.网络建模确定了 miR-204 靶向的分子功能,以抑制头颈部肿瘤转移。
PLoS Comput Biol. 2010 Apr 1;6(4):e1000730. doi: 10.1371/journal.pcbi.1000730.
8
miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer.miR-145 和 miR-133a 作为肿瘤抑制因子发挥作用,直接调控膀胱癌中 FSCN1 的表达。
Br J Cancer. 2010 Mar 2;102(5):883-91. doi: 10.1038/sj.bjc.6605570. Epub 2010 Feb 16.
9
[The roles of miR-17-92 cluster in mammal development and tumorigenesis].[miR-17-92簇在哺乳动物发育和肿瘤发生中的作用]
Yi Chuan. 2009 Nov;31(11):1094-100. doi: 10.3724/sp.j.1005.2009.01094.
10
Identification of transgelin-2 as a biomarker of colorectal cancer by laser capture microdissection and quantitative proteome analysis.通过激光捕获显微切割和定量蛋白质组分析鉴定结蛋白-2 作为结直肠癌的生物标志物。
Cancer Sci. 2010 Feb;101(2):523-9. doi: 10.1111/j.1349-7006.2009.01424.x. Epub 2009 Nov 3.